Published on
June 11, 2020
- 11:30 GMT
Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial ...
28 patients have completed the open-label Edge trial measuring IGF-1 levels after 13 weeks of treatment when patients with acromegaly were switched to once daily oral paltusotine from commercially available depot injections of the peptide somatostatin …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
